Business

Eli Lilly stock disappoints as obesity drug sales disappoint.



Eli Lilly

Shares fell on Thursday as the drug company’s heavily hyped obesity drug sales fell short. However, fourth-quarter earnings exceeded estimates.

shares in

Eli Lilly

(ticker: LLY) fell 2.9% in premarket trading. Futures contract tracking

S&P 500

rose 0.5%, by comparison.

goznews

Goz News: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably.

Related Articles

Back to top button